- $4.42bn
- $4.38bn
- $630.04m
- 67
- 18
- 55
- 44
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 298 | 352 | 443 | 538 | 630 |
Cost of Revenue | |||||
Gross Profit | 213 | 261 | 339 | 408 | 476 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 343 | 389 | 473 | 627 | 725 |
Operating Profit | -45.4 | -37.8 | -29.4 | -88.8 | -94.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -47.3 | -48.7 | -39.1 | -89 | -124 |
Provision for Income Taxes | |||||
Net Income After Taxes | -47.5 | -48.4 | -37.7 | -90.9 | -128 |
Net Income Before Extraordinary Items | |||||
Net Income | -47.5 | -48.4 | -37.7 | -90.9 | -128 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -47.5 | -48.4 | -37.7 | -90.9 | -128 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.03 | -0.999 | -0.738 | -1.71 | -2.35 |